- 专利标题: Targeting immunotherapy for amyloidosis
-
申请号: US15504512申请日: 2015-08-24
-
公开(公告)号: US10213506B2公开(公告)日: 2019-02-26
- 发明人: Jonathan S. Wall , Stephen J. Kennel , James S. Foster
- 申请人: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- 申请人地址: US TN Knoxville
- 专利权人: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- 当前专利权人: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- 当前专利权人地址: US TN Knoxville
- 代理机构: FisherBroyles, LLP
- 代理商 Jason M. Pass
- 国际申请: PCT/US2015/046523 WO 20150824
- 国际公布: WO2016/032949 WO 20160303
- 主分类号: A61K38/17
- IPC分类号: A61K38/17 ; A61P27/02 ; A61K39/395 ; C07K16/18 ; C07K14/47 ; A61K51/10 ; G01N33/53 ; G01N33/68 ; A61K47/66 ; A61K47/68 ; A61K39/00
摘要:
Disclosed are methods and compositions for targeting antibodies to amyloid deposits. For example, amyloid-reactive peptides that bind amyloid deposits are administered to a subject. Antibodies to the amyloid-reactive peptides are then administered to the subject. Upon administration of the antibodies, the amyloid-reactive peptides bind the antibodies and thus pre-target the antibodies to the amyloid deposits. In other examples, an amyloid-reactive fusion peptide contains an epitope of a known antibody. When the fusion peptide is administered to a subject, the fusion peptide binds amyloids in the subject. Administration to the subject of the known antibody that binds the epitope of the fusion peptide then targets the antibody to the amyloid deposit to which the fusion peptide is bound.
公开/授权文献
- US20170281807A1 TARGETING IMMUNOTHERAPY FOR AMYLOIDOSIS 公开/授权日:2017-10-05
信息查询
IPC分类: